Eisai Co., Ltd. (ESAIY)

Market Cap	8.84B +15.4%
Revenue (ttm)	5.15B +2.1%
Net Income	272.70M -27.3%
EPS	0.97 -26.6%
Shares Out	n/a
PE Ratio	32.42
Forward PE	n/a
Dividend	1.05 (15.01%)
Ex-Dividend Date	Mar 30, 2026

Volume	32,112
Average Volume	114,758
Open	7.82
Previous Close	7.75
Day's Range	7.80 - 7.85
52-Week Range	5.94 - 9.22
Beta	-0.26
RSI	63.49
Earnings Date	Feb 9, 2026

About Eisai

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1941
• Employees: 10,917
• Stock Exchange: OTCMKTS
• Ticker Symbol: ESAIY

Financial Performance

In fiscal year 2025, Eisai's revenue was 789.40 billion, an increase of 6.42% compared to the previous year's 741.75 billion. Earnings were 46.43 billion, an increase of 9.49%.

Financial numbers in JPY